Pyrimidine compounds and their use as pharmaceuticals

US5602136A · kind A · utility

Assignee

• Beiersdorf-Lilly GmbH · DE

Inventors

• Gerd R uhter · Hamburg, DE
• Theo Schotten · Winsen (Luhe), DE
• Wolfgang Stenzel · Reinbek, DE
• Michael Paal · Hamburg, DE

Key dates

• Filing date: May 26, 1995
• Grant date: Feb 11, 1997
• Expiry date: May 26, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds having the formula ##STR1## and the other variables are as defined herein, and are indicated for use in the treatment and prophylaxis of, for example, hypertension, congestive heart failure, ocular hypertension, renal failure, and CNS disorders, or are intermediates thereto.